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Physiologic effects of nasopharyngeal administration of supplemental
oxygen at various flow rates in healthy neonatal foals
Abstract
Objective—To evaluate the effects of various flow rates of oxygen administered via 1 or 2 nasal cannulae on
the fraction of inspired oxygen concentration (Fio2) and other arterial blood gas variables in healthy neonatal
foals.
Animals—9 healthy neonatal (3- to 4-day-old) foals.
Procedures—In each foal, a nasal cannula was introduced into each naris and passed into the nasopharynx to
the level of the medial canthus of each eye; oxygen was administered at 4 flow rates through either 1 or both
cannulae (8 treatments/foal). Intratracheal Fio2, intratracheal end-tidal partial pressure of carbon dioxide, and
arterial blood gas variables were measured before (baseline) and during unilateral and bilateral
nasopharyngeal delivery of 50, 100, 150, and 200 mL of oxygen/kg/min.
Results—No adverse reactions were associated with administration of supplemental oxygen except at the
highest flow rate, at which the foals became agitated. At individual flow rates, significant and dose-dependent
increases in Fio2, Pao2, and oxygen saturation of hemoglobin (Sao2) were detected, compared with baseline
values. Comparison of unilateral and bilateral delivery of oxygen at similar cumulative flow rates revealed no
differences in evaluated variables.
Conclusions and Clinical Relevance—Results indicated that administration of supplemental oxygen via
nasal cannulae appeared to be a highly effective means of increasing Fio2, Pao2, and Sao2 in neonatal foals.
These findings may provide guidance for implementation of oxygen treatment in hypoxemic neonatal foals.
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Administration of supplemental oxygen is com-monly performed to increase the oxygen content 
of blood in hypoxemic neonatal foals.1 In a neonatal 
foal, oxygen can be provided via a face mask, nasal can-
nula, or transtracheal catheter or by means of mechani-
cal ventilation involving endotracheal intubation.1–3 
Of these 4 methods of oxygen administration, a nasal 
cannula might perhaps cause the least discomfort and 
be the most practical, cost-effective, and frequently 
used method.1,3 Despite the frequent administration of 
supplemental oxygen in equine neonatal medicine, de-
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Objective—To evaluate the effects of various flow rates of oxygen administered via 1 or 
2 nasal cannulae on the fraction of inspired oxygen concentration (Fio
2
) and other arterial 
blood gas variables in healthy neonatal foals.
Animals—9 healthy neonatal (3- to 4-day-old) foals.
Procedures—In each foal, a nasal cannula was introduced into each naris and passed into 
the nasopharynx to the level of the medial canthus of each eye; oxygen was administered 
at 4 flow rates through either 1 or both cannulae (8 treatments/foal). Intratracheal Fio
2
, in-
tratracheal end-tidal partial pressure of carbon dioxide, and arterial blood gas variables were 
measured before (baseline) and during unilateral and bilateral nasopharyngeal delivery of 
50, 100, 150, and 200 mL of oxygen/kg/min.
Results—No adverse reactions were associated with administration of supplemental oxy- 
gen except at the highest flow rate, at which the foals became agitated. At individual flow 
rates, significant and dose-dependent increases in Fio2, Pao2, and oxygen saturation of he-
moglobin (Sao2) were detected, compared with baseline values. Comparison of unilateral 
and bilateral delivery of oxygen at similar cumulative flow rates revealed no differences in 
evaluated variables.
Conclusions and Clinical Relevance—Results indicated that administration of supplemen-
tal oxygen via nasal cannulae appeared to be a highly effective means of increasing Fio
2
, 
Pao
2
, and Sao
2
 in neonatal foals. These findings may provide guidance for implementation of 
oxygen treatment in hypoxemic neonatal foals. (Am J Vet Med 2010;71:1081–1088)
tailed investigation of the effects of flow rate (ie, dos-
age) of oxygen on arterial blood gas variables and Fio
2
 
in foals has not been undertaken, to our knowledge. In 
previous studies,3,4 oxygen at a flow rate of 10 L/min was 
administered via a face mask or nasal catheter to foals at 
30 minutes to 7 days after birth. The treatments resulted 
in significant increases in Pao
2
, compared with pretreat-
ment values; however, effects on Fio
2
 and the use of differ-
ent flow rates of oxygen were not investigated.3,4
Despite the obvious benefits gained from admin-
istration of supplemental oxygen, such as treatment of 
hypoxemia and reductions in ventilator requirements 
and myocardial effort necessary to maintain a given 
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AbbreviAtions
ALI  Acute lung injury
ARDS  Acute respiratory distress syndrome
Fio
2
  Fraction of inspired oxygen concentration
Petco
2
  End-tidal partial pressure of carbon 
   dioxide
pHa  Arterial blood pH
Sao
2
  Oxygen saturation of hemoglobin 
   in arterial blood
TCO
2
  Total carbon dioxide concentration
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alveolar oxygen tension, awareness of potential detri-
mental effects of prolonged exposure to supraphysio-
logic concentrations of inspired oxygen administered to 
foals should be considered.3 Relatively minor complica-
tions associated with supplemental oxygen administra-
tion include nasal irritation and rhinitis, airway drying, 
and stimulation of excessive airway secretions.1 How-
ever, hyperoxemia may result in the generation of reac-
tive oxygen species that are injurious to the lungs and 
other organs through oxidative stress.5,6 For example, 
it is known that fatal ALI develops in mice that are ex-
perimentally exposed to 100% oxygen for 4 days.7 Fur-
thermore, hyperoxic conditions result in DNA damage 
in lung tissue of mice, and hyperoxia has been associ-
ated with direct toxic effects in the lungs and the devel-
opment of bronchopulmonary dysplasia in premature 
infants.8–10 In general, to decrease the likelihood of oxi-
dative stress and damage, it is recommended to main-
tain the Fio
2
 at ≤ 60% if supplemental oxygen is to be 
administered for a prolonged (> 24 hours) period.11,12 
Thus, equine clinicians should attempt to maintain an 
Fio2 < 60% when administering supplemental oxygen 
to foals; however, the relationship between flow rate 
and Fio
2
 in neonatal foals is currently not known.
Knowledge of Fio
2
 in foals that are being adminis-
tered supplemental oxygen also would be useful in grad-
ing pulmonary disease severity in affected foals. Acute 
lung injury and ARDS are syndromes of noncardiogenic 
respiratory failure that have been widely recognized in 
people and less well described in foals.13–17 These syn-
dromes are characterized by diffuse alveolar damage. In 
horses, diagnosis of these syndromes requires that at 
least 4 of 5 criteria are met: acute onset of tachypnea and 
labored breathing at rest; presence of risk factors such 
as inflammation, infection, sepsis, or trauma; evidence 
of pulmonary capillary leakage without increased pul-
monary capillary pressure (eg, radiographic evidence of 
diffuse pulmonary infiltrates); evidence of diffuse pul-
monary inflammation; and evidence of inefficient gas 
exchange (derived via determination of the Pao
2
:Fio
2
 
ratio).15 With regard to gas exchange, ALI in horses is 
characterized by a Pao
2
:Fio
2
 ratio < 300 mm Hg (but 
> 200 mm Hg), whereas ARDS is characterized by a 
Pao
2
:Fio
2
 ratio < 200 mm Hg.15,16 However, the Pao
2
:Fio
2
 
ratio has not been specifically investigated in healthy 
neonatal foals, to our knowledge. In addition, the Fio
2
 
must be assessed to determine whether a foal has ALI 
or ARDS. Although the Fio
2
 in foals that are breath-
ing room air or being ventilated mechanically may be 
known, the Fio
2
 in foals that are receiving oxygen via 
intranasal administration has not been determined. The 
purpose of the study reported here was to evaluate the 
effects of different flow rates of oxygen administered 
via 1 or 2 nasal cannulae on the Fio
2
 and other arterial 
blood gas variables in healthy neonatal foals. We sought 
to establish a dosage protocol for supplemental oxygen 
delivery via nasal cannulae in foals. We hypothesized 
that increasing oxygen flow rates would increase Fio
2
 
and Pao
2
 in a dose-dependent manner.
Materials and Methods
Foals—For the investigation, 9 healthy neonatal 
foals from Iowa State University’s teaching herd were 
used. Each foal was considered healthy on the basis of 
physical examination findings, adequate passive trans-
fer of maternal antibodies (plasma immunoglobulin 
concentration at 24 hours after birth, ≥ 800 mg/dL), 
and the absence of any disorders in the dam during 
pregnancy or parturition. The duration of gestation 
in all foals was considered normal. Breeds included 
Thoroughbreds (n = 5) and Quarter Horses and re-
lated breeds (4). There were 5 fillies and 4 colts. The 
foals’ ages ranged from 3 to 5 days (mean ± SD age, 
3.9 ± 0.5 days), and weights ranged from 55 to 67 kg 
(mean weight, 60.4 ± 3.8 kg). The study protocol was 
approved by the Iowa State University Animal Care and 
Use Committee.
Instrumentation—On the day of the experimental 
procedure, each foal was weighed, a physical examina-
tion was performed, and rectal temperature, heart rate, 
and respiratory rate were recorded. The haired skin 
over the left dorsal metatarsal artery was clipped and 
prepared aseptically for catheter placement. A local an-
esthetic creama was applied liberally in the region of 
the dorsal metatarsal artery at least 10 minutes prior to 
catheter placement. The foal was sedated with diaze-
pamb (0.16 mg/kg, IV) and placed in right lateral recum-
bency. Subsequently, 0.25 mL of 2% lidocainec was in-
jected ID in the skin superficial to the dorsal metatarsal 
artery. A 20-gauge, 1.5-inch, over-the-needle intra-arte-
rial catheterd was placed under aseptic conditions into 
the dorsal metatarsal artery, and a low-volume (0.9-mL) 
extension sete was attached; the apparatus was secured 
with adhesive and protected with a bandage.
While the foal was still sedated, a polyethylene 
sampling linef (outer diameter, 3 mm) was inserted 
through the left ventral meatus with the guidance of a 
preplaced nasotracheal tubeg (internal diameter, 8 mm); 
the sampling line was advanced into the trachea to a 
point just caudal to the thoracic inlet for measurement 
of Fio
2
 and Petco
2
. Placement of the tracheal catheter 
was confirmed radiographically. Additionally, a nasal 
cannula (internal diameter, 4 mm) that was made of 
soft plastic tubingh was inserted into each ventral me-
atus so that the tip of each cannula was positioned in 
the nasopharynx at the level of the medial canthus of 
the eye. Each cannula was secured in place with tape 
and sutures.
Experimental protocol—Baseline values of rectal 
temperature, heart rate, and respiratory rate were re-
corded at least 1 hour after administration of the seda-
tive, while each foal was standing. Immediately after 
collection of those baseline data, a baseline arterial 
blood sample (2 mL) was collected anaerobically into 
syringes containing heparin; syringes were immedi-
ately placed in an ice bath, and samples were analyzed 
within 10 minutes by use of a blood gas analyzer.i The 
blood gas analyzer was calibrated with reagent packs 
and gas standards prior to and every hour during each 
experimental procedure. Arterial blood samples were 
evaluated in duplicate; findings were corrected to rectal 
temperature, and the mean value for each variable was 
calculated.
Following collection of the baseline blood sample, 
each nasal cannula was connected to an individual air 
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humidifierj and flow meterk and then connected to a 
flow splitter and a high-pressure tank that contained 
medical-grade (100%) oxygen. The tracheal catheter 
was interfaced with an airway gas analyzerl that mea-
sured Fio
2
 and Petco
2
. The analyzer was calibrated 
prior to each procedure by use of gas supplied by the 
manufacturer. Each foal was observed for coughing, be-
havioral changes, or adverse effects during the approxi-
mately 3-hour experimental procedure period.
Each foal was manually restrained in a standing po-
sition in the stall with the mare present. Oxygen admin-
istration at the first predetermined rate was initiated, 
and a minimum of 5 minutes elapsed before measure-
ments were made. A previous study3 in foals revealed 
that a 2-minute interval is adequate for equilibration. 
During the 5-minute equilibration period, the rate at 
which Fio
2
 changed along with the fluctuations in Fio
2
 
was subjectively assessed until a stable reading was es-
tablished. In 5 foals, oxygen was initially administered 
bilaterally (ie, through both nasal cannulae) and 4 rates 
of oxygen administration were evaluated. The flow rate 
for each cannula was initially 50 mL of oxygen/kg/min, 
which was adjusted to 100, 150, and 200 mL of oxy-
gen/kg/min in sequence (total dosages of 100, 200, 300, 
and 400 mL of oxygen/kg/min, respectively). Those to-
tal dosages of supplemental oxygen corresponded to 6, 
12, 18, and 24 L/min, respectively, in a 60-kg foal. In 
those 5 foals, oxygen was subsequently administered 
in the same sequence of increasing flow rates through 
only 1 randomly selected (ie, left or right) cannula 
(total dosages of 50, 100, 150, and 200 mL of oxygen/
kg/min). Those total dosages of supplemental oxygen 
corresponded to 3, 6, 9, and 12 L/min, respectively, in 
a 60-kg foal. In the other 4 foals, oxygen was initially 
administered bilaterally (ie, through both nasal cannu-
lae) and the same 4 rates of oxygen administration were 
evaluated. However, the flow rate for each cannula was 
initially 200 mL of oxygen/kg/min, which was adjusted 
to 150, 100, and 50 mL of oxygen/kg/min in sequence 
(total dosages of 400, 300, 200, and 100 mL of oxy-
gen/kg/min, respectively). In those 4 foals, oxygen was 
subsequently administered in the same sequence of de-
creasing flow rates through only 1 randomly selected 
(ie, left or right) cannula (total dosages of 200, 150, 
100, and 50 mL of oxygen/kg/min). On the day that a 
foal was to be used in an experimental procedure, it was 
allocated to receive one or the other of the dosage regi-
mens on an alternating schedule (ie, evaluated foals 1, 
3, 5, 7, and 9 received the increasing flow rate regimen 
and evaluated foals 2, 4, 6, and 8 received the decreas-
ing flow rate regimen).
For all foals, a minimum of 5 minutes was allowed 
to elapse before measurements were made at each flow 
rate; data collection at each flow rate was completed 
within 10 minutes. If a foal became excited during han-
dling, it was allowed to regain a quiet demeanor with 
minimal restraint prior to collection of data. At each 
flow rate, measurements included assessments of rec-
tal temperature, heart rate, and respiratory rate and 
the Fio
2
 and Petco
2
 values were obtained from a gas 
sample aspirated through the tracheal catheter; an arte-
rial blood sample (2 mL) was collected and analyzed, as 
described. At the end of data collection at each oxygen 
flow rate, the foal was disconnected from all monitors 
and external devices and was allowed free access to the 
mare for at least 10 minutes. Prior to administration of 
oxygen at the various oxygen flow rates, the Fio
2
 was 
evaluated to ensure that no residual effects from previ-
ous oxygen administration were present.
Statistical analysis—All data are reported as mean 
± SD. A repeated-measures ANOVA was applied to each 
of the response variables (rectal temperature, heart rate, 
respiratory rate, Fio
2
, pHa, Pao
2
, Paco
2
, Petco
2
, blood 
bicarbonate concentration, TCO
2
, Sao
2
, and Pao
2
:Fio
2
 
ratio) by use of computer software.m For each response 
variable, an F test with Kenward and Roger adjustment 
to degrees of freedom was used to test for differences 
among the variable means of 9 data groups (baseline 
values and 8 treatment groups [bilateral administration 
of oxygen at rates of 50, 100, 150, or 200 mL/kg/min 
and unilateral administration of oxygen at rates of 50, 
100, 150, and 200 mL/kg/min]) with significance set at 
a value of P < 0.05. When a significant F test was calcu-
lated, post hoc Tukey t tests were applied for pairwise 
comparisons between treatment means. To evaluate 
the effects of oxygen flow rate on 2 particular response 
variables, Fio
2
 and Pao
2
, a linear regression analysis 
with repeated measures was applied to each of the re-
sponses by use of computer software.m The coefficient 
of determination also was calculated for the regression 
model for each response variable. In addition, the cor-
relation coefficient between Paco
2
 and Petco
2
 was esti-
mated and testedn for significance. A value of P < 0.05 
was considered significant.
Results
There were no complications associated with in-
strumentation or data collection in any foal. Most foals 
tolerated handling and restraint calmly, but some foals 
became excited; those foals were allowed to regain a 
quiet demeanor prior to collection of data. No adverse 
effects were observed during administration of oxygen 
at the lower flow rates (50, 100, and 150 mL/kg/min). 
However, foals developed signs of agitation during 
oxygen administration at the highest flow rate (200 
mL/kg/min) exemplified by head tossing, rubbing of 
the muzzle, and hyperesthesia, regardless of whether 
oxygen was administered via 1 or both nasal cannulae. 
There were no significant differences among foals with 
regard to rectal temperature, heart rate, or respiratory 
rate at any oxygen flow rate, compared with baseline 
values (Table 1). Likewise, comparisons of data ob-
tained at the various oxygen flow rates revealed no sig-
nificant difference in rectal temperature, heart rate, or 
respiratory rate, with the exception of a significant (P 
= 0.04) difference in respiratory rate between unilat-
eral administration of oxygen at a rate of 50 mL/kg/min 
and bilateral administration of oxygen at a rate of 100 
mL/kg/min.
Data regarding Fio
2
, pHa, Pao
2
, Paco
2
, Petco
2
, 
blood bicarbonate concentration, TCO
2
, Sao
2
, and Pao
2
:
Fio
2
 ratio were obtained for all foals at each oxygen 
flow rate (Table 2). The Fio
2
 measurement fluctuated, 
depending on the foal’s activity and respiratory rate, 
but generally increased and reached a plateau within 
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30 to 60 seconds of the commencement of oxygen ad-
ministration at each flow rate. Compared with baseline 
values, significant (P < 0.001) increases in Fio
2
, Pao
2
, 
and Sao
2
 were detected at all oxygen flow rates. Other 
significant differences from baseline values included 
changes in pHa during unilateral delivery of oxygen at 
a rate of 200 mL/kg/min (P = 0.04) and in Paco
2
 during 
unilateral delivery at rates of 100 and 200 mL/kg/min 
and during bilateral delivery at a rate of 100 mL/kg/min 
(P ≤ 0.04). Compared with baseline values, there were 
no significant differences in values of Petco
2
, blood bi-
carbonate concentration, and TCO
2
 at any oxygen flow 
rate, regardless of delivery method.
Administration of supplemental oxygen increased 
Fio
2
 and Pao2 in a dose-dependent manner. However, 
at any given flow rate, measured variables were not af-
fected by delivery method (ie, unilateral or bilateral ad-
ministration). More specifically, values of the measured 
variables obtained during unilateral administration of 
100 mL of oxygen/kg/min did not differ significantly 
from those obtained during bilateral administration 
of 50 mL of oxygen/kg/min; similarly, values of the 
measured variables obtained during unilateral adminis-
tration of 200 mL of oxygen/kg/min did not differ sig-
nificantly from those obtained during bilateral admin-
istration of 100 mL of oxygen/kg/min.
In addition, comparisons among individual oxygen 
flow rates delivered by either method revealed signifi-
cant (P ≤ 0.02) differences in Fio
2
, with the exception 
of 100 mL/kg/min administered bilaterally versus 150 
mL/kg/min administered unilaterally, 150 mL/kg/min 
administered bilaterally versus 200 mL/kg/min admin-
istered unilaterally, and 150 mL/kg/min administered 
unilaterally versus 200 mL/kg/min administered uni-
laterally. Also, comparisons among individual oxygen 
flow rates delivered by either method revealed signifi-
cant (P ≤ 0.03) differences in Pao
2
, with the exception 
of 100 mL/kg/min administered bilaterally versus 150 
mL/kg/min administered bilaterally, 100 mL/kg/min 
administered bilaterally versus 150 mL/kg/min admin-
	 Oxygen delivery
 Unilateral (mL/kg/min) Bilateral (mL/kg/min) 
Variable Baseline 50 100 150 200 50 100 150 200
Respiratory rate  39  12 52  10a 47  15 44  11 40  15 38  10 37  11b 44  8 42  12
  (breaths/min)
Heart rate  94  10 101  6 101  8 101  19 98  19 95  11 97 12 96  12 95  10
  (beats/min)
Temperature (°C) 38.4  0.4 38.7  0.3 38.6  0.3 38.6  0.4 38.6  0.3 38.4  0.3 38.6  0.4 38.5  0.4 38.5  0.4
a,bWithin a row, mean values with different superscript letters differ significantly (adjusted P  0.04) .
Table 1—Mean ± SD respiratory rate, heart rate, and rectal temperature in 9 healthy neonatal foals before (baseline) and during admin-
istration of supplemental oxygen at various flow rates via 1 or 2 nasal cannulae (unilateral and bilateral oxygen delivery, respectively).
 Oxygen delivery
	 Unilateral (mL/kg/min) Bilateral (mL/kg/min) 
Variable Baseline 50 100 150 200 50 100 150 200
Fio2 (%) 18.0  0.7
a 23.0  1.4b 30.9  2.1b 44.2  5.8b,c,d 52.6  8.3b,d,e 30.9  2.6b 48.7  6.2b,c 56.4  3.4b,e 74.6  4.2b
pHa 7.435  0.02a 7.415  0.02 7.417  0.01 7.418  0.01 7.411  0.02b 7.422  0.01 7.412  0.02 7.422  0.03 7.426  0.02
Pao2 (mm Hg) 92.5  8.2
a 135.9  13.2b 175.2  14.6b 219.6  31.9b,e,f 269.7  40.8b,d,f 174.3  26.8b 261.2  38.3b,c,e 307.8  41.0b,c,d 374.2  58.2b
Paco2 (mm Hg) 47.7  2.8
a 49.7  2.4 50.5  2.3b 50.1  2.8 51.3  3.1b 49.8  1.8 51.0  2.2b 49.8  2.9 48.6  3.6
Petco2 (mm Hg) 53.9  3.3 52.6  4.9 52.8  7.9 53.9  7.9 54.6  5.6 55.6  2.8 55.3  6.0 55.2  5.1 55.3  4.8
Bicarbonate (mmol/L) 31.4  2.7 30.7  1.3 31.4  1.2 31.2  1.3 31.4  1.2 30.8  1.9 31.5  1.4 31.4  2.0 30.8  2.2
TCO2 (mmol/L) 32.3  2.0 32.0  1.5 32.8  1.3 32.6  1.3 32.8  1.3 32.2  2.0 32.9  1.4 32.8  2.1 32.2  2.3
Sao2 (%) 96.7  0.7
a 98.5  0.3b 99.2  0.1b 99.4  0.2b 99.6  0.1b 99.1  0.3b 99.6  0.1b 99.7  0.1b 99.8  0.1b
Pao2:Fio2 ratio 514  39 594  73
g,h 569  61 502  75g 517  58 563  55 540  73 547  81 501  57h
a,bWithin a row, mean baseline value and and values at individual oxygen flow rates that have different superscript letters differ sig-
nificantly (P  0.05). c–f Within a row, Fio2 or Pao2 at individual oxygen flow rates that have different superscript letters differ significantly 
(P ≤ 0.02 and ≤ 0.03, respectively) . g,hWithin a row, mean ratio values at individual oxygen flow rates that have different superscript letters 
differ significantly (P  0.05).
Table 2—Mean ± SD arterial blood gas and tracheal gas variables in 9 healthy neonatal foals before (baseline) and during administration 
of supplemental oxygen at various flow rates via 1 or 2 nasal cannulae (unilateral and bilateral oxygen delivery, respectively).
Variable Delivery method Derived equation P value
Fio2 Unilateral Fio2 = 17.33 + (0.1297 X oxygen flow/cannula)  0.001	 Bilateral Fio2 = 17.33 + (0.2665 X oxygen flow/cannula)  0.001
Pao2 Unilateral Pao2 = 91.93 + (0.8247 X oxygen flow/cannula)  0.001	 Bilateral Pao2 = 91.93 + (1.4513 X oxygen flow/cannula)  0.001
Table 3—Linear regression analysis results for Fio
2
 and Pao
2
 in 9 healthy neonatal foals that were administered supplemental oxygen at 
various flow rates via 1 or 2 nasal cannulae (unilateral and bilateral oxygen delivery, respectively).
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istered unilaterally, 150 mL/kg/min administered bilat-
erally versus 200 mL/kg/min administered unilaterally, 
and 150 mL/kg/min administered unilaterally versus 
200 mL/kg/min administered unilaterally. With regard 
to the Pao
2
:Fio
2
 ratio, a significant difference between 
200 mL of oxygen/kg/min administered bilaterally and 
50 mL of oxygen/kg/min administered unilaterally (P 
= 0.03) and between 50 mL of oxygen/kg/min admin-
istered unilaterally and 150 mL of oxygen/kg/min ad-
ministered unilaterally (P = 0.04) was detected. No sig-
nificant differences in pHa, Paco2, Petco2, blood bicar-
bonate concentration, and TCO
2
 were identified among 
individual oxygen flow rates.
Linear regression analysis yielded equations for Fio
2
 
and Pao2 associated with unilateral or bilateral oxygen 
delivery (Table 3). The coefficient of determination was 
0.9223 for the regression model of Fio
2
 and 0.8632 for 
the regression model of Pao2. In other words, the linear 
regression model could explain 92.23% and 86.32% of 
the variation in Fio
2
 and Pao2, respectively. There was 
a significant correlation (r = 0.497; P < 0.001) between 
Paco
2
 and Petco2.
Discussion
Results of the study reported here indicated that 
Pao2 and Fio2 increased in a dose-dependent manner as 
the flow of supplemental oxygen into the nasopharynx 
of healthy neonatal foals increased. Intuitively, this was 
an expected response to oxygen administration. Never-
theless, these findings support the rationale for naso-
pharyngeal administration of supplemental oxygen in 
hypoxemic foals and provide a dosage guide for oxygen 
administration as well as expected changes in Pao
2
 and 
Fio
2
 in response to treatment with oxygen in healthy 
neonatal foals. Also, data obtained in the present study 
indicated that measured variables did not differ when 
oxygen was administered at a specific flow rate through 
1 or 2 nasal cannulae; this suggests that oxygen ad-
ministration via 1 nasal cannula can provide adequate 
changes in Fio2 and Pao2, within certain flow rate limits. 
If a maximum increase in Fio2 in healthy neonatal foals 
is desired, nasopharyngeal administration of oxygen at 
a rate of 200 mL/kg/min simultaneously in each naris 
(400 mL/kg/min total) can increase the Fio
2
 to approxi-
mately 75%.
Physiologically, nasopharyngeal administration of 
oxygen increases the Fio
2
, thereby allowing higher con-
centrations of oxygen to reach the alveoli; consequently, 
this creates a higher concentration gradient of oxygen 
between the alveoli and arterial blood within the pul-
monary vasculature. The increase in Fio2 is a result of 
direct flow of supplemental oxygen into the trachea and 
the capacity of the nasopharynx to act as a reservoir for 
inspired air (ie, oxygen).12 During supplemental oxygen 
administration, the nasopharynx is progressively filled 
with higher concentrations of oxygen, particularly dur-
ing the pause in air movement between expiration and 
inspiration. The fixed volume of air contained within 
the nasopharynx is gradually filled with supraphysi-
ologic concentrations of oxygen, thereby increasing 
the Fio
2
 upon inspiration.12 The pause between expira-
tion and inspiration will vary with the respiratory rate; 
therefore, higher oxygen flow rates may be necessary to 
achieve anticipated Fio
2
 values in animals with higher 
respiratory rates.18 This is supported by the fact that 
Fio
2
 is inversely related to respiratory rate in infants re-
ceiving oxygen via intranasal administration.18,19 Other 
factors that affect the Fio
2
 in infants and foals include 
cannula flow rate, the Fio
2
 in the cannula gas flow, pa-
tency of cannula openings, placement of the nasal can-
nula, patient’s body weight, minute ventilation, and the 
relative duration of inspiration and expiration.1,19
On the basis of the present study’s results, it is ap-
parent that there is a rapid change in Fio
2
 and Pao
2
 in 
response to administration of supplemental oxygen in 
healthy neonatal foals. Increases in Fio
2
 were observed 
within 30 to 60 seconds after commencement of oxygen 
administration, similar to findings in other species.12 
In addition, based on the rapid decrease in Fio
2
 once 
supplemental oxygen administration was discontinued, 
clearance of oxygen was rapid—a factor that should be 
considered when administering supplemental oxygen 
in a clinical setting. Another point of interest was the 
irritation or discomfort caused by unilateral or bilateral 
intranasal administration of oxygen at a flow rate of 200 
mL/kg/min in the foals in the present study. However, 
the authors have administered supplemental oxygen at 
flow rates > 200 mL/kg/min to ill neonatal foals without 
observing adverse effects. It is likely that ill neonatal 
foals are lethargic and less responsive to the irritation 
caused by high rates of oxygen administration. None-
theless, if nasal irritation or discomfort develops during 
unilateral administration of oxygen at a specific flow 
rate, distribution of the same total flow rate through 
2 nasal cannulae may be a viable alternative delivery 
method. Despite the high flow rates of oxygen, no re-
tardation of exhalation or trapping of carbon dioxide 
was evident in the foals of the present study. Although 
there was a significant increase in Paco
2
 during unilat-
eral administration of oxygen at flow rates of 100 and 
200 mL/kg/min and during bilateral administration at 
a flow rate of 200 mL/kg/min, compared with baseline 
values, the degree of hypercapnea was considered clini-
cally unimportant in the healthy study foals. Moreover, 
no significant differences were detected between base-
line Petco
2
 and Petco
2
 values at the individual oxygen 
flow rates. However, in infant studies,20,21 the admin-
istration of oxygen via nasal cannula generated posi-
tive end-expiratory pressure, depending on the size of 
the nasal cannula (with respect to infant size) and flow 
rate. Therefore, it is possible that positive end-expira-
tory pressure can be generated in neonatal foals receiv-
ing supplemental oxygen via nasal cannula, particularly 
in ill foals that have decreased or weakened respiratory 
effort as a result of exhaustion or weak contraction of 
respiratory muscles.1 This can potentially result in el-
evated airway pressure with both positive (increased 
functional residual capacity, alveolar recruitment, and 
improvement in ventilation-perfusion matching) and 
negative (retention of carbon dioxide and hypercapnia) 
consequences, especially at high oxygen flow rates.1,21
The relationship and correlation between Paco2 
and Petco
2
 has been examined in various studies22–24 in 
efforts to use Petco
2
 as a less invasive means of moni-
toring Paco
2
 in clinical cases such as emergency room 
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admissions and during anesthesia; overall correlation 
between these 2 variables has been high in several stud-
ies22–24 in people. Likewise, a significant correlation be-
tween Paco
2
 and Petco
2
 was determined in the healthy 
neonatal foals used in the present study. However, the 
actual correlation between Petco
2
 and Paco
2
 was only 
moderate (r = 0.497). This can be partially explained by 
the fact that administration of supplemental oxygen had 
a significant effect on Paco
2
 but not on Petco
2
. There-
fore, oxygen administration accounted for part of the 
variation in Paco
2
 that was not correlated with Petco2. 
Nevertheless, it is possible that Petco
2
 could be used 
to reflect and monitor changes in Paco
2
 in ill foals, al-
though further studies are necessary. It should be noted 
that the gas sample used for measurement of Petco
2
 in 
the present study was aspirated from the intrathoracic 
portion of the trachea rather than from the nares or na-
sopharynx, which are more easily accessible locations 
and are more likely to be used for Petco
2
 measurement 
in ill foals. The possibility that the anatomic location 
at which Petco
2
 is measured may change Petco
2
 values 
slightly requires further investigation.
One important reason to attempt to estimate Fio
2
 is 
the ability to use the Pao
2
:Fio
2
 ratio to evaluate pulmo-
nary gas exchange in hypoxemic patients and to assess 
respiratory tract disease severity. Acute lung injury is 
defined as a Pao
2
:Fio
2
 ratio < 300 mm Hg (but > 200 
mm Hg), whereas ARDS is defined as a Pao
2
:Fio2 ratio 
< 200 mm Hg (along with other previously described 
criteria).14–16 Specific modifications to the definition of 
ALI and ARDS have been made to account for the docu-
mented changes in gas exchange efficiency that develop 
in neonatal foals (< 7 days old) as well as in infants.15,25 
In the consensus definitions of ALI and ARDS in veteri-
nary medicine, the threshold of equine neonatal ALI is 
defined as a Pao
2
:Fio
2
 ratio of < 250 mm Hg, whereas 
equine neonatal ARDS is defined as a Pao2:Fio2 ratio of 
< 160 mm Hg at 4 days after birth.15 The Pao2:Fio2 ratio 
that was considered normal in that report15 was a value 
> 400 mm Hg. In the study reported here, the mean 
Pao
2
:Fio
2
 ratio in healthy neonatal foals (mean age, 3.9 
days) ranged from 501 to 594 mm Hg and was estab-
lished in standing foals that were, at times, receiving 
intranasal administration of supplemental oxygen. The 
difference in the Pao2:Fio2 ratio between the present 
and previous studies15,26,27 may be explained, in part, by 
the fact that the consensus definitions were based on 
arterial blood gas values from foals that were breathing 
room air in lateral recumbency, a position that is known 
to decrease Pao
2
 values. Overall, only a few veterinary 
reports13,14 have documented the use of the Pao
2
:Fio
2
 
ratio in foals, and accordingly, the use of the Pao
2
:Fio
2
 
ratio in neonatal foals with pulmonary diseases is in 
its infancy. The information obtained from the study 
of this report confirmed that the mean Pao
2
:Fio
2
 ratio 
in healthy neonatal foals that are breathing room air 
should be approximately 500 mm Hg (range, 477 to 594 
mm Hg). Furthermore, this information can be used to 
estimate the Fio
2
 in hypoxemic neonatal foals, which 
will facilitate the further investigation of the Pao
2
:Fio
2
 
ratio in clinical cases. Clearly, additional studies are 
necessary to assess Pao
2
:Fio
2
 ratio values in foals with 
ALI or ARDS and evaluate the sensitivity and specificity 
of the extrapolated threshold ratios for diagnosis of ALI 
and ARDS in neonatal foals.
Another reason to be aware of the Fio
2
 induced 
by administration of supplemental oxygen in neonatal 
foals is to avoid development of oxygen toxicosis as a 
result of high flow rates of oxygen. On the basis of the 
findings of the present study, it is unlikely that the rec-
ommended maximum Fio
2
 (60%) during supplemental 
oxygen administration or mechanical ventilation11,12 
would be exceeded, particularly with unilateral admin-
istration of the oxygen dosages investigated. However, 
in severely hypoxemic neonatal foals, bilateral nasal 
cannulae have been used to administer oxygen in com-
bined flow rates of up to 30 L/min (eg, administration 
of 250 mL of oxygen/kg/min in each naris in a 60-kg 
foal).1 The maximum mean Fio
2
 measured in the pres-
ent study was approximately 75% when foals received 
oxygen intranasally at a rate of 200 mL/kg/min bilat-
erally. Maintenance of a unilateral oxygen flow rate of 
≤ 200 mL/kg/min or a bilateral flow rate of ≤ 150 mL/
kg/min should avoid excessively high Fio
2
 concentra-
tions in neonatal foals, if prolonged intranasal adminis-
tration of oxygen is necessary. The guidelines set forth 
by the Society of Critical Care Medicine recommend 
that the lowest possible Fio
2
 should be used at all times 
to achieve treatment goals and should not exceed 50% 
in patients with respiratory failure.28
Although it is important to be cognizant of the Fio
2
 
to avoid development of oxygen toxicosis and to evalu-
ate the efficacy of pulmonary gas exchange, the clinical 
endpoints of supplemental oxygen administration are 
improved Pao
2
 and Sao
2
. The value of Pao
2
 in foals re-
ceiving unilateral administration of oxygen intranasally 
at a flow rate of 200 mL/kg/min in the present study 
(mean Pao
2
, 269.7 mm Hg) was similar to the finding in 
slightly younger foals receiving unilateral administra-
tion of oxygen intranasally at a flow rate of 10 L/min in 
another study3 (mean Pao
2
, 268.5 mm Hg). At the flow 
rates used in the present study, the mean maximum 
Pao
2
 values that could be achieved via unilateral and 
bilateral intranasal oxygen administration in healthy 
neonatal foals are approximately 270 and 375 mm Hg, 
respectively. However, this information is of limited 
clinical use in ill neonatal foals with compromised 
cardiopulmonary function (ie, diffusion impairment, 
ventilation-perfusion mismatch, or intrapulmonary or 
intracardiac right-to-left shunting of blood) that results 
in impaired alveolar gas exchange and hypoxemia.29 For 
example, in 1 study,30 the mean Pao
2
 value in response 
to administration of supplemental oxygen via facemask 
was significantly decreased in abnormal neonatal foals, 
compared with the value in similarly treated healthy 
neonatal foals (mean Pao
2
, 129.4 and 312.8 mm Hg, 
respectively). Therefore, adjustment of the flow rate 
of supplemental oxygen in ill foals with cardiopulmo-
nary disease should be based on evaluation of the re-
sponse to supplemental oxygen administration (eg, 
measurement of Pao
2
 and Sao
2
). Physiologically, as 
Pao
2
 increases, Sao
2
 concomitantly increases. Not 
surprisingly, Sao
2
 increased from baseline (as Pao
2
 
increased) during oxygen administration at all of the 
flow rates used in the present study. Recommended 
therapeutic goals of oxygen administration in neona-
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tal foals include maintenance of Pao
2
 at 80 to 110 mm 
Hg and Sao
2
 > 90%.1,28
In the study reported here, other significant differ-
ences in measured variables were detected when find-
ings at the individual oxygen flow rates were compared 
with baseline values or with one another. Compared 
with the baseline value, there was a significant decrease 
in pHa during unilateral administration of oxygen at a 
rate of 200 mL/kg/min, but the difference between the 
2 values (0.024) is not likely to have any clinical im-
portance. Furthermore, the exact reason why respira-
tory rate during unilateral administration of 100 mL of 
oxygen/kg/min and during bilateral administration of 
100 mL of oxygen/kg/min differed significantly is un-
known. Although restraint of the foals could have re-
sulted in excitement, no specific explanation could be 
provided for this observation.
One distinct limitation of the present study that 
should be highlighted was the varied temperaments of 
the foals. Most foals tolerated handling and restraint 
without resentment. However, some foals became very 
excited upon handling, which increased heart and re-
spiratory rates and potentially altered the variables be-
ing measured. In particular, Fio2 appeared to fluctuate 
the most, depending on the foal’s activity and respira-
tory rate. If a foal was excited, the investigators allowed 
the foal to regain a quiet demeanor with minimal re-
straint prior to collection of data. Nonetheless, the few 
highly anxious foals may have provided skewed results. 
Another limitation of the study was that the foals were 
all in good health, and the response to nasopharyngeal 
administration of supplemental oxygen may be differ-
ent in ill neonatal foals with pulmonary disease. Evalu-
ation of the response to nasopharyngeal administration 
of oxygen at different flow rates in ill neonatal foals, in-
cluding those with pulmonary diseases, is warranted.
Results of the present study have indicated that 
nasopharyngeal administration of supplemental oxy-
gen effectively increases Fio
2
, Pao
2
, and Sao
2
 and allows 
clinicians to estimate Fio
2
 in neonatal foals. Previously 
recommended oxygen flow rates in foals vary from 2 to 
15 L/min, depending on the size, needs, and response 
of the foal.1,31,32 Information obtained from the present 
study has provided linear regression equations to esti-
mate the Fio
2
 (based on body weight) in neonatal foals 
in response to different oxygen flow rates and to predict 
the response (ie, Pao2) to a specific oxygen flow rate in 
healthy neonatal foals and subsequently compare this 
theoretical response with the response of an ill foal. It 
should be emphasized that the findings of the present 
study and the linear regression equations are estimates 
of Fio
2
 and Pao
2
 in response to nasopharyngeal admin-
istration of supplemental oxygen in healthy standing 
neonatal foals and should not be used as absolute ther-
apeutic values or goals. Adequate response to oxygen 
administration is best evaluated by monitoring arterial 
blood gas variables such as Pao
2
 and Sao
2
 and the clini-
cal response of the patient.
a. Xylocaine (2%) jelly, AstraZeneca, Wilmington, Del.
b. Diazepam, Hospira, Lake Forest, Ill.
c. Lidocaine 2%, Hospira, Lake Forest, Ill.
d. Quickflash radial artery catheterization set, Arrow Internation-
al, Reading, Pa.
e. Minivolume extension set, Baxter Healthcare Corp, Deerfield, 
Ill.
f. Criticare Systems, Waukesha, Wis.
g. Smiths Medical, Dublin, Ohio.
h. Duodenal tube, Rusch, Kernen, Germany.
i. Rapidlab, Bayer Healthcare, Tarrytown, NY.
j. Aquapak, Hudson Respiratory Care, Research Triangle Park, 
NC.
k. Timeter flow meter, Allied Healthcare Products, St Louis, Mo.
l. Poet IQ, Criticare Systems, Waukesha, Wis.
m. Mixed procedure, SAS, version 9.1.3, SAS Institute Inc, Cary, 
NC.
n. Correlation procedure, SAS, version 9.1.3, SAS Institute Inc, 
Cary, NC.
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